Search Results 91-100 of 306 for ❣베스트토토안전확인【평생베스트.com】베스트토토검증완료❣

  1. Tests and Procedures - Mayo Clinic

    Featured topics · Cancer · Cardiovascular Diseases and Surgery · Neurology and Neurosurgery · Transplant.

  2. A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease - Mayo Clinic

    The primary objective is to evaluate whether macitentan 10 mg reduces N-terminal pro-brain natriuretic peptide (NT-pro-BNP) as compared to placebo in these ...

  3. Application for Self-Monitoring of Cardiovascular Risk - Mayo Clinic

    ... best. Study IDs. Site IRB. Rochester, Minnesota: 11-004546. NCT ID: NCT01883050. Sponsor Protocol Number: 11-004546. About this study. Patients who recently ...

  4. A Phase 1/2 Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Glanzmann Thrombasthenia - Mayo Clinic

    The purpose of this study is to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Participants with Glanzmann ...

  5. Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or In Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

    ... best. Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  6. A Study of DCC-2618 vs. Sunitinib in Advanced GIST Patients after Treatment with Imatinib - Mayo Clinic

    ... best. Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  7. Publications

    Publications. Shanafelt TD, West CP, Sinsky C, Trockel M, Tutty M, Wang H, Carlasare LE, Dyrbye LN. Changes in Burnout and Satisfaction With Work-Life ...

  8. Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders. - Mayo Clinic

    ... best. Study IDs. NCT ID: NCT01574703. Sponsor Protocol Number: A3051148. About this study. Non-treatment extension to study A3051123, aimed at collecting data ...

  9. ALTA TIPS: A 5-year Longitudinal Observational Study of Patients Undergoing TIPS Placement - Mayo Clinic

    ... best. Study IDs. Site IRB. Rochester, Minnesota: 19-002650. NCT ID: NCT03973372. Sponsor Protocol Number: STU00208288. About this study. ALTA is a multicenter ...

  10. A Dose-Ranging Study to Determine the Effectiveness, Safety and Tolerability of AeroFact - Mayo Clinic

    The purpose of this two-part Phase 2 study is to assess the safety, tolerability and efficacy of aerosolized SF-RI 1 (AeroFact) when delivered via nCPAP at two ...